Insights On CONTRACT PHARMA MANUFACTURING

  1. Bridging The Gap During Organizational Restructuring For Long Term Continuity 8/11/2025

    Explore project continuity for a pharmaceutical client during restructuring by providing trained on-site experts, implementing operational excellence, and meeting milestones despite senior staff turnover.

  2. The Rise Of Targeted Modalities In Pharmaceutical Development 8/11/2025

    Targeted modalities are pushing the boundaries of technology and therapeutic effectiveness. Their potential to transform patient care depends on leveraging the right expertise, technologies, and partnerships.

  3. Targeted Protein Degraders: Transforming Oral Therapeutics 8/11/2025

    CDMOs play a critical role in TPD development by offering specialized infrastructure and analytical capabilities to support the transition from preclinical research to clinical supply and commercialization.

  4. Targeted Modalities: Trends, Challenges, CDMO Considerations 8/11/2025

    Targeted modalities are designed to bind specifically to receptors or biological targets, ensuring a more directed and effective treatment while reducing systemic exposure and unintended side-effects.

  5. Simtra BioPharma Solutions Capacity Update July 2025: ADC 8/7/2025

    MilliporeSigma and Simtra's streamlined collaboration encompasses every stage, including bioconjugation, linker and payload supplies, formulation development, and final fill/finish of drug substance.

  6. Particles In High Concentration Biotherapeutics 8/7/2025

    Examine advanced analytical solutions that detect, characterize, and mitigate particle formation in high-concentration biotherapeutics caused by protein aggregation and surfactant degradation.

  7. Best Practices For Regulatory Excellence In Clinical Research 8/7/2025

    Observe how GCLP can integrate ethical and technical standards to ensure reliable, compliant clinical trial data and optimize laboratory operations across sponsors, CROs, and partners.

  8. Advancing mRNA Vaccines and Therapeutics Through IVT Process Development 8/7/2025

    An optimized in vitro transcription (IVT) platform enables scalable, high-yield, and cost-efficient mRNA therapeutic production by leveraging data-driven process optimization and enzyme innovation to overcome key manufacturing challenges.

  9. Tech Transfer Strategies For mAb Drug Products In Late-Phase Launch 8/7/2025

    Tech transfer is not just a process of replicating manufacturing steps; it is a complex, multidisciplinary effort that ensures process robustness, scalability, regulatory compliance, and supply chain readiness.

  10. How Compliance-Driven CDMOs Win Sponsor Contracts 8/6/2025

    Discover how evolving global regulations are reshaping CDMO strategy. and how digital infrastructure helps manufacturers stay audit-ready, build sponsor trust, and turn compliance into an advantage.